Human_JJ
immunodeficiency_NN
virus-associated_JJ
Hodgkin_NN
's_POS
disease_NN
derives_VBZ
from_IN
post-germinal_JJ
center_NN
B_NN
cells_NNS
._.

Human_JJ
immunodeficiency_NN
virus-associated_JJ
Hodgkin_NN
's_POS
disease_NN
-LRB-_-LRB-
HIV-HD_NN
-RRB-_-RRB-
displays_VBZ
several_JJ
peculiarities_NNS
when_WRB
compared_VBN
with_IN
HD_NN
of_IN
the_DT
general_JJ
population_NN
._.

These_DT
include_VBP
overrepresentation_NN
of_IN
clinically_RB
aggressive_JJ
histologic_JJ
types_NNS
and_CC
frequent_JJ
infection_NN
of_IN
Reed-Sternberg_NN
-LRB-_-LRB-
RS_NN
-RRB-_-RRB-
cells_NNS
by_IN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
._.

Recently_RB
,_,
we_PRP
have_VBP
reported_VBN
that_IN
the_DT
histogenesis_NN
of_IN
HD_NN
of_IN
the_DT
general_JJ
population_NN
may_MD
be_VB
assessed_VBN
by_IN
monitoring_VBG
the_DT
expression_NN
pattern_NN
of_IN
BCL-6_NN
,_,
a_DT
transcription_NN
factor_NN
expressed_VBN
in_IN
germinal_JJ
center_NN
-LRB-_-LRB-
GC_NN
-RRB-_-RRB-
B_NN
cells_NNS
,_,
and_CC
of_IN
CD138\/syndecan_NN
-1_CD
-LRB-_-LRB-
syn-1_NN
-RRB-_-RRB-
,_,
a_DT
proteoglycan_NN
associated_VBN
with_IN
post-GC_JJ
,_,
terminal_JJ
B-cell_NN
differentiation_NN
._.

In_IN
this_DT
study_NN
,_,
we_PRP
have_VBP
applied_VBN
these_DT
two_CD
markers_NNS
to_TO
the_DT
study_NN
of_IN
HIV-HD_NN
histogenesis_NN
and_CC
correlated_VBD
their_PRP$
expression_NN
status_NN
to_TO
the_DT
virologic_JJ
features_NNS
of_IN
this_DT
disease_NN
._.

We_PRP
have_VBP
found_VBN
that_IN
RS_NN
cells_NNS
of_IN
all_DT
histologic_JJ
categories_NNS
of_IN
HIV-HD_NN
consistently_RB
display_VBP
the_DT
BCL-6_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
\/_:
syn-1_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
phenotype_NN
and_CC
thus_RB
reflect_VBP
post-GC_JJ
B_NN
cells_NNS
._.

Although_IN
BCL-6_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
\/_JJ
syn-1_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
RS_NN
cells_NNS
of_IN
HIV-HD_NN
express_VBP
CD40_NN
,_,
they_PRP
are_VBP
not_RB
surrounded_VBN
by_IN
CD40_NN
ligand-positive_NN
-LRB-_-LRB-
CD40L_NN
+_NN
-RRB-_-RRB-
reactive_JJ
T_NN
lymphocytes_NNS
,_,
which_WDT
,_,
in_IN
HD_NN
of_IN
the_DT
general_JJ
population_NN
,_,
are_VBP
thought_VBN
to_TO
regulate_VB
the_DT
disease_NN
phenotype_NN
through_IN
CD40\/CD40L_NN
interactions_NNS
._.

Conversely_RB
,_,
RS_NN
cells_NNS
of_IN
virtually_RB
all_DT
HIV-HD_NN
express_VBP
the_DT
EBV-encoded_JJ
latent_JJ
membrane_NN
protein_NN
1_CD
-LRB-_-LRB-
LMP1_NN
-RRB-_-RRB-
,_,
which_WDT
,_,
being_VBG
functionally_RB
homologous_JJ
to_TO
CD40_NN
,_,
may_MD
contribute_VB
,_,
at_IN
least_JJS
in_IN
part_NN
,_,
to_TO
the_DT
modulation_NN
of_IN
the_DT
HIV-HD_NN
phenotype_NN
._.

